Hepatocellular carcinoma (HCC) is the most common primary liver cancer whose incidence
continues to rise in many parts of the world due to a concomitant rise in many associated risk …

Background Hepatocellular carcinoma (HCC) is the most common form of primary liver
cancer and is the third-leading cause of cancer-related death worldwide. Most patients with …

Background: In 2020, atezolizumab-bevacizumab became the new standard of care (SOC)
for first-line unresectable hepatocellular carcinoma (HCC) patients, following a decade …

Introduction: The etiology of liver diseases has changed significantly, but its impact on the
comparative burden of cirrhosis between males and females is unclear. We estimated sex …

Dextrin is a polysaccharide but is small and of low complexity. Naringin is a flavonoid widely
known for its pharmacological properties. This study aimed to create a naringin–dextrin …

Biomarkers associated with hepatocellular carcinoma (HCC) are of great importance to
better understand biological response mechanisms to internal or external intervention. The …

Hepatocellular carcinoma (HCC) stands as the most common cancer type, arising from
various causes, and responsible for a substantial number of cancer-related fatalities. Recent …

Introduction: The etiology of liver diseases has changed significantly, but its impact on the
comparative burden of cirrhosis between males and females is unclear. We estimated sex …

Liver tumors rank as the fourth most common cause of cancer. This case report highlights a
45-year-old female patient who presented persistent abdominal pain and no other …

Cirrhosis is a chronic, diffuse disease process characterized by fibrosis and remodeling of
the organ's normal architectonics into regenerative nodules. It is also one of the risk factors …